Involvement and dual effects of nitric oxide in septic shock
- PMID: 9628258
- DOI: 10.1007/s000110050309
Involvement and dual effects of nitric oxide in septic shock
Abstract
Bacterial endotoxin (LPS) releases many mediators such as interleukins, tumour necrosis factor, oxygen free radicals, toxic eicosanoids, platelet activating factor, and nitric oxide (NO). LPS is a potent inducer of inducible nitric oxide synthase (iNOS). Large amounts of NO (made by iNOS) and peroxynitrite, among other factors, are responsible for the late phase of hypotension, vasoplegia, cellular suffocation, apoptosis, lactic acidosis and multiorgan failure in endotoxic shock. Indeed, experimental and clinical use of NOS inhibitors, which do not differentiate clearly between constitutive endothelial NOS (ceNOS) and iNOS, prevents LPS-induced hypotension. However, many detrimental effects of such NOS inhibitors are also reported, including increases in pulmonary resistance, decreases in cardiac output and organ perfusion, and even an increase in mortality of experimental animals. We believe that, in lungs, NO made by ceNOS plays a protective role against the pneumotoxic effects of LPS-released lipids such as thromboxane, leukotrienes and PAF. This is why selective iNOS inhibitors like aminoguanidine or thiourea derivatives might be preferred over nonselective NOS inhibitors for the treatment of septic shock. However, since iNOS-derived NO seems to have more than just a destructive action, the selective iNOS inhibition may be not as beneficial as expected. Accordingly, inhalation of NO gas or NO-donors in septic shock might be a complementary treatment to the use of NOS inhibitors.
Similar articles
-
Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.J Biomed Sci. 1999 Jan;6(1):28-35. doi: 10.1007/BF02256421. J Biomed Sci. 1999. PMID: 9933740
-
Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide.Thromb Haemost. 2001 Dec;86(6):1573-7. Thromb Haemost. 2001. PMID: 11776329
-
The lung is the major site that produces nitric oxide to induce acute pulmonary oedema in endotoxin shock.Clin Exp Pharmacol Physiol. 2001 Apr;28(4):315-20. doi: 10.1046/j.1440-1681.2001.03446.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11251647
-
Alterations in nitric oxide production in various forms of circulatory shock.New Horiz. 1995 Feb;3(1):2-32. New Horiz. 1995. PMID: 7535648 Review.
-
Nitric oxide in shock.Kidney Int. 2007 Sep;72(5):557-65. doi: 10.1038/sj.ki.5002340. Epub 2007 May 30. Kidney Int. 2007. PMID: 17538569 Review.
Cited by
-
Expression and cellular localization of inducible nitric oxide synthase in lipopolysaccharide-treated rat kidneys.J Histochem Cytochem. 2012 Apr;60(4):301-15. doi: 10.1369/0022155411436131. Epub 2012 Jan 19. J Histochem Cytochem. 2012. PMID: 22260992 Free PMC article.
-
Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis.J Clin Invest. 2000 Nov;106(10):1271-80. doi: 10.1172/JCI10793. J Clin Invest. 2000. PMID: 11086028 Free PMC article.
-
EVALUATION OF HYPERALGESIA AND HISTOLOGICAL CHANGES OF DORSAL ROOT GANGLION INDUCED BY NUCLEUS PULPOSUS.Rev Bras Ortop. 2015 Dec 12;45(5):460-7. doi: 10.1016/S2255-4971(15)30436-5. eCollection 2010 Sep-Oct. Rev Bras Ortop. 2015. PMID: 27022595 Free PMC article.
-
A Protective Role of Glibenclamide in Inflammation-Associated Injury.Mediators Inflamm. 2017;2017:3578702. doi: 10.1155/2017/3578702. Epub 2017 Jun 27. Mediators Inflamm. 2017. PMID: 28740332 Free PMC article. Review.
-
Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus.Br J Pharmacol. 2002 Jul;136(5):645-58. doi: 10.1038/sj.bjp.0704734. Br J Pharmacol. 2002. PMID: 12086974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
